First, we transfected U2OS osteosarcoma cells harboring an inducible MYC transgene (U2OSMYC-Tet-On) with an siRNA pool targeting MYC, then re-established MYC expression with doxycycline (“MYC ON,” Figure 2F). Here, MYC is linked to osteosarcoma.